Integrating Metastasectomy in the Management of Advanced Urological Malignancies-Where are we in 2005?

Journal of Urology

Volumn 176, Issue 5, 2006, Pages 1921-1926

  Rasco, Drew W ^a   Assikis, Vasily ^a   Marshall, Fray ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

carcinoma, renal cell; neoplasm metastasis; testis; urological neoplasms; urothelium

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

BLADDER CARCINOMA; BONE METASTASIS; BRAIN METASTASIS; CANCER SURGERY; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; MEDICAL LITERATURE; MEDLINE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; TESTIS CARCINOMA; TREATMENT OUTCOME; UROGENITAL TRACT TUMOR;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 33750364323     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.07.003     Document Type: Review

References (50)

1. Einhorn L.H., Williams S.D., Mandelbaum I., and Donohue J.P. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 48 (1981) 904
2. Logothetis C.J., Samuels M.L., Trindade A., and Johnson D.E. The growing teratoma syndrome. Cancer 50 (1982) 1629
3. Sundaresan N., Rothman A., Manhart K., and Kelliher K. Surgery for solitary metastases of the spine: rationale and results of treatment. Spine 27 (2002) 1802
4. Piltz S., Meimarakis G., Wichmann M.W., Hatz R., Schildberg F.W., and Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73 (2002) 1082
5. Kierney P.C., van Heerden J.A., Segura J.W., and Weaver A.L. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1 (1994) 345
6. van der Poel H.G., Roukema J.A., Horenblas S., van Geel A.N., and Debruyne F.M. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35 (1999) 197
7. Law C.H., Wei A.C., Hanna S.S., Al-Zahrani M., Taylor B.R., Greig P.D., et al. Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome. Ann Surg Oncol 10 (2003) 922
8. Kavolius J.P., Mastorakos D.P., Pavlovich C., Russo P., Burt M.E., and Brady M.S. Resection of metastatic renal cell carcinoma. J Clin Oncol 16 (1998) 2261
9. Jackson R.J., Gokaslan Z.L., and Loh S.A. Metastatic renal cell carcinoma of the spine: surgical treatment and results. J Neurosurg 94 (2001) 18
10. Jung S.T., Ghert M.A., Harrelson J.M., and Scully S.P. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 409 (2003) 223
11. Cerfolio R.J., Allen M.S., Deschamps C., Daly R.C., Wallrichs S.L., Trastek V.F., et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57 (1994) 339
12. Pfannschmidt J., Hoffmann H., Muley T., Krysa S., Trainer C., and Dienemann H. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74 (2002) 1653
13. Tanguay S., Swanson D.A., and Putnam J.B. Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery. J Urol 156 (1996) 1586
14. Alves A., Adam R., Majno P., Delvart V., Azoulay D., Castaing D., et al. Hepatic resection for metastatic renal tumors: is it worthwhile?. Ann Surg Oncol 10 (2003) 705
15. Stief C.G., Jahne J., Hagemann J.H., Kuczyk M., and Jonas U. Surgery for metachronous solitary liver metastases of renal cell carcinoma. J Urol 158 (1997) 375
16. Faure J.P., Tuech J.J., Richer J.P., Pessaux P., Arnaud J.P., and Carretier M. Pancreatic metastasis of renal cell carcinoma: presentation, treatment, and survival. J Urol 165 (2001) 20
17. Wronski M., Arbit E., Russo P., and Galicich J.H. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 47 (1996) 187
18. Vecil G.G., and Lang F.F. Surgical resection of metastatic intraventricular tumors. Neurosurg Clin N Am 14 (2003) 593
19. Daliani, D. D., Assikis, V. J., Thall, P., Wang, X., Jonasch, E., Putnam, J. B., Jr. et al: Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma. Unpublished data
20. Krishnamurthi V., Novick A.C., and Bukowski R.M. Efficacy of multimodality therapy in advanced renal cell carcinoma. Urology 51 (1998) 933
21. Sella A., Swanson D.A., Ro J.Y., Putnam J.B., Amaton R.J., Markowitz A., et al. Surgery following response to interferon-α-based therapy for residual renal cell carcinoma. J Urol 149 (1993) 19
22. Dodd P.M., McCaffrey J.A., Herr H., Mazumdar M., Bacik J., Higgins G., et al. Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. J Clin Oncol 17 (1999) 2546
23. Miller R.S., Freiha F.S., Reese J.H., Ozen H., and Torti F.M. Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J Urol 150 (1993) 65
24. Otto T., Krege S., Suhr J., and Rübben H. Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial. Urology 57 (2001) 55
25. Siefker-Radtke A.O., Walsh G.L., Pisters L.L., Shen Y., Swanson D.A., Logothetis C.J., et al. Is there a role for surgery in the management of metastatic urothelial cancer?. The M. D. Anderson experience J Urol 171 (2004) 145
26. Brenner P.C., Herr H.W., Morse M.J., Sheinfeld J., Aprikian A., Bosl G.J., et al. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. J Clin Oncol 14 (1996) 1765
27. Hartmann J.T., Schmoll H.J., Kuczyk M.A., Candelaria M., and Bokemeyer C. Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. Ann Oncol 8 (1997) 531
28. Steyerberg E.W., Donohue J.P., Gerl A., Toner G.C., Koops H.S., Fossa S.D., et al. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. J Urol 158 (1997) 474
29. Fizazi K., Tjulandin S., Salvioni R., Germà-Lluch J.R., Bouzy J., Ragan D., et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy-results from an international study group. J Clin Oncol 19 (2001) 2647
30. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15 (1997) 594
31. Albers P., Ganz A., Hannig E., Miersch W.E., and Müller S.C. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 164 (2000) 381
32. Eastham J.A., Wilson T.G., Russell C., Ahlering T.E., and Skinner D.G. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 43 (1994) 74
33. Murphy B.R., Breeden E.S., Donohue J.P., Messemer J., Walsh W., Roth B.J., et al. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11 (1993) 324
34. Anyanwu E., Krysa S., Buelzebruck H., and Vogt-Moykopf I. Pulmonary metastasectomy as secondary treatment for testicular tumors. Ann Thorac Surg 57 (1994) 1222
35. Cagini L., Nicholson A.G., Horwich A., Goldstraw P., and Pastorino U. Thoracic metastasectomy for germ cell tumours: long term survival and prognostic factors. Ann Oncol 9 (1998) 1185
36. Liu D., Abolhoda A., Burt M.E., Martini N., Bains M.S., Downey R.J., et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 66 (1998) 1709
37. George D.W., Foster R.S., Hromas R.A., Robertson K.A., Vance G.H., Ulbright T.M., et al. Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 21 (2003) 113
38. Hahn T.L., Jacobson L., Einhorn L.H., Foster R., and Goulet Jr. R.J. Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol 6 (1999) 640
39. Goulet Jr. R.J., Hardacre J.M., Einhorn L.H., Loehrer P.J., Jones J.A., Donohue J.P., et al. Hepatic resection for disseminated germ cell carcinoma. Ann Surg 212 (1990) 290
40. Rivoire M., Elias D., De Cian F., Kaemmerlen P., Théodore C., and Droz J.P. Multimodality treatment of patients with liver metastases from germ cell tumors. Cancer 92 (2001) 578
41. Bokemeyer C., Nowak P., Haupt A., Metzner B., Köhne H., Hartmann J.T., et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 15 (1997) 1449
42. Mahalati K., Bilen C.Y., Özen H., Aki F.T., and Kendi S. The management of brain metastasis in nonseminomatous germ cell tumours. BJU Int 83 (1999) 457
43. Spears W.T., Morphis II J.G., Lester S.G., Williams S.D., and Einhorn L.H. Brain metastases and testicular tumors: long-term survival. Int J Radiat Oncol Biol Phys 22 (1992) 17
44. Herr H.W., Sheinfeld J., Puc H.S., Heelan R., Bajorin D.F., Mencel P., et al. Surgery for a post-chemotherapy residual mass in seminoma. J Urol 157 (1997) 860
45. Ravi R., Ong J., Oliver R.T.D., Badenoch D.F., Fowler C.G., and Hendry W.F. The management of residual masses after chemotherapy in metastatic seminoma. BJU Int 83 (1999) 649
46. Mencel P.J., Motzer R.J., Mazumdar M., Vlamis V., Bajorin D.F., and Bosl G.J. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 12 (1994) 120
47. McCutcheon I.E., Eng D.Y., and Logothetis C.J. Brain metastasis from prostate cancer. Cancer 86 (1999) 2301
48. Chao D.H., Higgins J.P., and Brooks J.D. Biochemical remission after resection of prostate cancer lung metastasis. Urology 63 (2004) 584
49. Cusan L., Gomez J.L., Dupont A., Diamond P., Lemay M., Moore S., et al. Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamide. Prostate 24 (1994) 257
50. Fabozzi S.J., Schellhammer P.F., and el-Mahdi A.M. Pulmonary metastases from prostate cancer. Cancer 75 (1995) 2706